Nasal spray made from stem cell-derived vesicles could treat Alzheimer’s disease

A new therapy may delay Alzheimer’s disease progression by years, according to a study by researchers at Texas A&M University College of Medicine. Published in the Journal of Extracellular Vesicles, the research aims to explore treatment options for Alzheimer’s, which constitutes the most common form of dementia and is a leading cause of death among those aged 65 or older, afflicting nearly 7 million Americans.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup